Sen. Maggie Hassan questions Trump administration over mystery weight loss drug patient [View all]
Source: MS NOW News
Jun. 24, 2026, 7:30 PM EDT
Sen. Maggie Hassan, D-N.H., on Wednesday questioned the Trump administration over the mystery individual who got exclusive access to a new weight loss drug that is not available to the general public. Hassan penned a letter to Health and Human Services Secretary Robert F. Kennedy Jr. expressing concern over reports that a well-connected individual, whom she suggested is President Donald Trump, received special, free access to the experimental weight loss drug retatrutide.
The New Hampshire Democrat shared the letter with MS NOW in an exclusive interview with The Weeknight. Weve got somebody highly connected in this administration whos making special deals for one person and it just speaks to the whole way this administration operates, Hassan told MS NOW. Theyre thinking about the highly connected, the wealthy.
In her letter to Kennedy, the congresswoman said she was concerned that the administration was bending the rules by giving an individual special access to the drug through the Food and Drug Administration. I am deeply concerned by new reporting that suggests you may be bending the rules of a federal program, and exerting improper political pressure, in order to provide a well-connected individual with free access to an exclusive prescription drug, the senator wrote to Kennedy.
Hassans letter comes a day after Stat News reported that drug manufacturer Eli Lilly and the Food and Drug Administration allowed special access to retatrutide for a lone 79-year-old man in April through its compassionate use program.
Read more: https://www.ms.now/news/maggie-hassan-retatrutide-patient-white-house
Link to Sen. Hassan
PRESS RELEASE -
Senator Hassan Presses for Answers After Reports That Trump May Have Received Special, Free Access to Medication as Prescription Costs Soar
Link to
LETTER (inquiry) (PDF) -
https://www.hassan.senate.gov/imo/media/doc/624.26lettertorfkjr.pdf